|
|
|
Dozens of oncology projects, combined with our staff of professionals with
advanced degrees in medicine, molecular biology, biochemistry and other pertinent
disciplines, enable a deep and broad understanding of this complex and constantly
evolving clinical arena. An ability to address complex disease pathways, molecular
diagnostics, and targeted treatment options drives reliable assumptions regarding
disease management. With our assistance, our clients have pioneered clinical trial
strategies and navigated differential pricing across indications.
Solid Tumors
- Basal Cell Carcinoma (BCC)
- Bladder
- Brain (Glioblastoma, Anaplastic Astrocytoma, Ependymoma)
- Breast
- Cervical
- Colorectal
- Head and Neck
- Kaposi's Sarcoma
- Kidney (Renal Cell)
- Liver (Hepatocellular)
- Lung (SCLC and NSCLC)
- Melanoma
- Ovarian
- Pancreatic
- Prostate
- Stomach (Gastric)
- Testicular
- Uterine
- Wilms' Tumor
Hematologic Cancers
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Cutaneous T-cell Lymphoma (CTCL)
- Hodgkin's Lymphoma (HL)
- Non-Hodgkin's Lymphoma (NHL)
|
|
 |
|
|
|
|
|
download
our our oncology brochure. (PDF 626KB)
learn more
about our work in oncology and hematology. |
|
|
|
|
 |
|
|